press-release

Exergen Corporation Receives Regulatory Approval to Launch Full Line of Temporal Artery Thermometers in Peru

Watertown, Mass, July 9, 2024 – Exergen Corporation, a pioneer in infrared thermometry technology, announces its receipt of approval from Peruvian regulatory authorities to introduce its comprehensive range of Temporal Artery Thermometers to the Peruvian market. The DIGEMID approval confirms that all Exergen thermometers comply with the rigorous standards for accuracy, reliability, and safety as […]

Exergen Corporation Receives Regulatory Approval to Launch Full Line of Temporal Artery Thermometers in Peru Read More »

Exergen Receives T&M Certification in India for its full Temporal Artery Thermometers Line

Watertown, MA, July 8, 2024 – Exergen Corporation, a global leader in infrared thermometry, is pleased to announce that it has received Testing and Measuring (T&M) certification from the Indian government based on the Legal Metrology Act for its Temporal Artery Thermometers. This significant certification marks a crucial step forward in providing state-of-the-art medical technology

Exergen Receives T&M Certification in India for its full Temporal Artery Thermometers Line Read More »

Exergen Appoints Roberto Silva de Brito as New Sales Representative in Brazil

Watertown, MA – June 26, 2024 – Exergen Corporation, a global leader in infrared temperature measurement technologies, is pleased to announce the appointment of Roberto Silva de Brito as the new sales representative for Brazil. Roberto Silva de Brito will report directly to Benjamin Kalm, Exergen’s Commercial Director for Latin America and the Caribbean.   Roberto

Exergen Appoints Roberto Silva de Brito as New Sales Representative in Brazil Read More »

Exergen Corporation Awarded New Patent for Inflammation Detection to Aid Diabetes Patients

Watertown, MA, May 30, 2024 – Exergen Corporation, a leader in infrared temperature measurement technologies, announced today that it has been granted a new patent for innovative devices and methods aimed at detecting inflammation, specifically designed to help diabetes patients monitor their health. The patent, titled “Devices and Methods for Detecting Inflammation,” represents a significant

Exergen Corporation Awarded New Patent for Inflammation Detection to Aid Diabetes Patients Read More »